New England Journal of MedicineOriginal article
Phase 3 Trial of Oral Infigratinib in Children with Achondroplasia
Phase 3InfigratinibNeutral
AI Analysis
Summary
New England Journal of Medicine publishes Phase 3 trial results of oral infigratinib in children with achondroplasia. The article appears in Volume 395, Issue 9, published September 3, 2026.
Clinical Trial Data
Phase
3
Importance:6/10
Sentiment:
0.00
Phase 3 TrialAchondroplasiaPediatricOral Therapy
Related Companies
Read the original article
Published by New England Journal of Medicine on June 28, 2026 8:00 AM